Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Positive; HER2/Neu Negative; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Bone; Progesterone Receptor Positive; Prognostic Stage IV Breast Cancer AJCC v8 Interventions: Drug: Anastrozole; Drug: Exemestane; Drug: Fulvestrant; Drug: Letrozole; Drug: Palbociclib; Radiation: Radiation Therapy; Drug: Tamoxifen Sponsors: Emory University; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Hormonal Therapy | Hormones | Pfizer | Radiation Therapy | Tamoxifen